课题基金 / 基金详情

Mechanisms of suppression of ischemiaa related arrhythmias for Na/H exchange inhibitors

Mechanisms of suppression of ischemiaa related arrhythmias for Na/H exchange inhibitors
Na/H交换抑制剂抑制缺血相关心律失常的机制
批准号:
11670085
负责人:
HASHIMOTO Keitaro
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

HASHIMOTO Keitaro的其他基金

相似基金

相关文献

中文摘要
翻译
选择性Na^+/H^+交换抑制剂在心肌缺血动物模型中显示出心脏保护作用。其中,cariporide、KB-R9032、SMP-300和FR168888对狗和大鼠冠状动脉结扎/再灌注诱导的VF有抑制作用,这可能是由于H^+挤压后Ca^<2+>过载所致。KB-R9032还能降低犬冠状动脉闭塞期间的室性早搏数。对狗和大鼠体内血流动力学参数无影响,对其他由洋地黄或肾上腺素引起的Ca^<2+>过载引起的心律失常无显著影响。在大鼠中,cariporide不抑制缺血预处理的抗心律失常作用。虽然几乎没有心电图变化来解释抗心律失常的作用,但在代谢方面的有利作用,如减弱大鼠心肌再灌注时磷酸肌酸过调。尽管有这些有利的动物数据,但初步临床试验并未显示出卡瑞波利对急性冠状动脉疾病的显著保护作用。一种新的选择性Na^+/Ca^+交换抑制剂KB-R7943对狗的再灌注VF和洋地黄心律失常没有显示出保护作用,尽管有有利的作用。
英文摘要
Selective Na^+/H^+ exchange inhibitors have been shown to have cardioprotective effects in animal models of myocardial ischemia. Among them, cariporide, KB-R9032, SMP-300 and FR168888 suppressed coronary ligation/reperfusion induced VF in dogs and rats, which might have been induced by Ca^<2+> overload after extrusion of H^+. KB-R9032 also decreased the number of PVCs during coronary occlusion in dogs. They had no effects on cardiohemodynamic parameters of in vivo dogs and rats, nor had no significant effects on other Ca^<2+> overload induced arrhythmias by digitalis or adrenaline. In rats, cariporide did not suppress antiarrhythmic effects of ischemic preconditioning. Though there were almost no ECG changes to explain antiarrhythmic effects, metabolically favorable effects, such as blunting creatine phosphate overshoot during reperfusion in rat myocardium were observed. Regardless of these favorable animal data, a preliminary clinical trial of cariporide did not show marked protective effect in acute coronary diseases. A new selective Na^+/Ca^+ exchange inhibitor, KB-R7943, did not show protective effect against against reperfusion VF and digitalis arrhythmias in dogs, though favorable effects have been reported in.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
Miyamoto S.: "QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide."Europ.J.Pharmacol.. 400. 263-269 (2000)
Miyamoto S.:“延长 QT 的 I 类药物丙吡胺不会加重但会抑制肾上腺素引起的心律失常。与西苯唑啉和匹西卡尼比较。”Europ.J.Pharmacol.. 400. 263-269 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakayama K.: "Arteriolar and venular vasodilating proterties of benodipine hydrochloride, a 1, 4-dihydropyridine Ca^<2+> antagonist with long- lasting action, assessed in rat mesenteric microcirculation."J.Cardiovasc. Pharmacol.. 33. 540-548 (1999)
Nakayama K.:“盐酸贝诺地平(一种具有持久作用的 1, 4-二氢吡啶 Ca^2 拮抗剂)的小动脉和静脉血管舒张特性,在大鼠肠系膜微循环中进行了评估。”J.Cardiovasc。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takusagawa M.: "The inhibitory effects of carvedilol against arrhythmias induced by coronary reperfusion in anesthetized rats."Cardiovasc Pharmacol Therapeut. 5 (2). 105-112 (2000)
Takusakawa M.:“卡维地洛对麻醉大鼠冠状动脉再灌注引起的心律失常的抑制作用。”Cardiovasc Pharmacol Therapeut。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sugiyama A.: "Cariporide, a highly seoective Na^+/H^+ exchange Inhibitor, suppresses the reperfusion-Induced lethal arrhythmias and "overshoot" phenomenon of creatine phosphate In situ rat heart."J.Cardiovasc. Pharmacol.. 33. 116-121 (1999)
Sugiyama A.:“Cariporide 是一种高度选择性的 Na^ /H^ 交换抑制剂,可抑制再灌注引起的致死性心律失常和磷酸肌酸原位大鼠心脏的“过冲”现象。”J.Cardiovasc。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 32 条
    Effects of Na/H and Na/Ca exchange inhibitors on ischemia/reperfusion arrhythmias
    • 批准号:
      13670081
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      HASHIMOTO Keitaro
    • 依托单位:
    Pharmacological prevention of sudden cardiac death
    • 批准号:
      11357020
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $23.07万
    • 财政年份:
      1999
    • 负责人:
      HASHIMOTO Keitaro
    • 依托单位:
    Electropharmacologycal therapy for lethal arrhythmias
    • 批准号:
      07307025
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $4.74万
    • 财政年份:
      1995
    • 负责人:
      HASHIMOTO Keitaro
    • 依托单位:
    Animal models for studying arrhythmogenic drug actions
    • 批准号:
      04454541
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.03万
    • 财政年份:
      1992
    • 负责人:
      HASHIMOTO Keitaro
    • 依托单位:
    国内基金
    海外基金
    靶向Na⁺-糖酵解轴:²³Na-MRI无创评估宫颈癌化疗耐药与疗效预测研究
    • 批准号:
      JCZRLH202600284
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    深紫外双折射晶体Na[BF2(CN)2]大尺寸单晶生长工艺研发
    • 批准号:
      JCZRQNB202600441
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    SCNN1G通过Na+/CSNK2A1/NF-κB轴塑造膀胱癌非炎症型微环境并介导免疫治疗耐药的机制研究
    Na2O-Salt-H2O体系盐介导干预下废SCR脱硝催化剂钠化反应的定向调控机制
    • 批准号:
      52564052
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32.00万元
    • 批准年份:
      2025
    • 负责人:
      曹才放
    • 依托单位: